Eric Siu breaks down why AG1 doesn't disclose ingredient doses, uses amounts below clinically effective levels, and relies on expensive podcast ads instead of proving the product works. The company's marketing spend raises questions about what it's actually selling.
AG1 has paid people who have trust with others. And if you look at the AG1 product, they have around 70 ingredients, 46 of which you have no idea the dose you're taking. The ingredients that they are disclosing, they skim, which means they're far below clinical-grade doses. And so what you're getting is basically a green salad. But the fact that they're not telling you what you're putting into your body is insane. Like, where else would that be okay? And so it's the entire structure that this company is spending tens of millions of dollars to pay people to read their script. These people will read the script happily because they're getting paid an enormous amount of money. I think you said $40 million a year on podcasts. We're all trying to dodge the dangers of society. So who's got our back? And so if a company's pulling up to say, I'm going to give you something that's actually good for you, surely they must have our back. Actually, no.
